Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Novel antiviral nucleoside analogues from Glaxo Wellcome, U. Michigan

Dec. 18, 1998

Macrolactam monosaccharide of microbial origin with antifungal and antibacterial activity

Dec. 18, 1998

Itraconazole prevents relapse of P. marneffei infection in HIV-infected patients

Dec. 17, 1998

Meiji Seika describes carbapenems with potent, broad-spectrum activity

Dec. 17, 1998

Agouron initiates human testing of antirhinoviral agent AG-7088

Dec. 17, 1998

TerraGen and Schering-Plough Research Institute establish collaborative agreement

Dec. 16, 1998

Another market introduction for imiquimod

Dec. 15, 1998

FDA approves expanded indication for CytoGam

Dec. 14, 1998

Broad-spectrum, water-soluble antiviral agent produced by Streptomyces discovered in Japan

Dec. 10, 1998

Pfizer produces novel erythromycins using precursor-directed biosynthetic technology

Dec. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...